Scherbaum W A, Bottazzo G F, Doniach D
Z Gesamte Inn Med. 1983 Feb 15;38(4):107-15.
The indirect immunofluorescence (IFL) test is the method of choice for the detection of new organ-specific autoantibodies. It is also the standard method of detection of antibodies to pancreatic islet cells, adrenal cortex, and steroid-producing cells in gonads and placenta. A positive test is the essential diagnostic step to find out the etiology of some endocrine diseases, but the significance of this method varies in different organs. There is as yet no substitute for the IFL test in the determination of single cell antibodies within organs e.g. antibodies to endocrine cells of the pituitary and the gut. In some clinical situations it is advisable to look for the complement-fixing ability of cytoplasmic autoantibodies using the CF-IFL test and for scientific investigation the IFL test can be applied when looking for antigens on the surface of cells in suspension or culture.
间接免疫荧光(IFL)试验是检测新的器官特异性自身抗体的首选方法。它也是检测胰腺胰岛细胞、肾上腺皮质以及性腺和胎盘类固醇生成细胞抗体的标准方法。阳性检测结果是查明某些内分泌疾病病因的关键诊断步骤,但该方法在不同器官中的意义有所不同。在确定器官内的单细胞抗体(如垂体和肠道内分泌细胞的抗体)方面,IFL试验尚无替代方法。在某些临床情况下,建议使用补体结合间接免疫荧光(CF - IFL)试验检测细胞质自身抗体的补体结合能力,而在科学研究中,当寻找悬浮或培养细胞表面的抗原时,可应用IFL试验。